Pharmacoscopy improves therapy for relapsed blood cancer in a first clinical trial

by CeMM Research Center for Molecular Medicine of the Austrian Academy of SciencesPatient cells imaged by pharmacoscopy. Credit: CeMM/Gregory VladimerResearchers at CeMM and the Medical University of

Updated on: April 22,2024

Pharmacoscopy improves therapy for relapsed blood cancer in a first clinical trial

by CeMM Research Center for Molecular Medicine of the Austrian Academy of SciencesPatient cells imaged by pharmacoscopy. Credit: CeMM/Gregory VladimerResearchers at CeMM and the Medical University of

Updated on:April 22,2024

FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T

Updated on: March 30,2024

FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T

Updated on:March 30,2024

Exome sequencing identifies those with cancer predisposition syndromes missed by current screening guidelines

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainAmong individuals who consented to whole-exome sequencing and were identified as carriers of predisposition genes for h

Updated on: January 08,2024

Exome sequencing identifies those with cancer predisposition syndromes missed by current screening guidelines

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainAmong individuals who consented to whole-exome sequencing and were identified as carriers of predisposition genes for h

Updated on:January 08,2024

Study finds cancer cells use a new fuel in absence of sugar

by Anna Megdell,University of MichiganProfiling of metabolite utilization in PDA cells identifies uridine. Credit:Nature(2023). DOI: 10.1038/s41586-023-06073-wResearchers at the Univ

Updated on: January 23,2024

Study finds cancer cells use a new fuel in absence of sugar

by Anna Megdell,University of MichiganProfiling of metabolite utilization in PDA cells identifies uridine. Credit:Nature(2023). DOI: 10.1038/s41586-023-06073-wResearchers at the Univ

Updated on:January 23,2024

One lung cancer drug receives NHS England approval, while another is rejected

by Cancer Research UKCredit: CC0 Public DomainA targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced lung cancer. But another precision d

Updated on: May 20,2024

One lung cancer drug receives NHS England approval, while another is rejected

by Cancer Research UKCredit: CC0 Public DomainA targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced lung cancer. But another precision d

Updated on:May 20,2024

Research: Subset of breast cancers have two PIK3CA mutations on the same allele

by Bob Yirka , Medical XpressCredit: CC0 Public DomainA team of researchers affiliated with a large number of institutions in the U.S. has found that a subgroup of breast cancers have two PIK3CA mutat

Updated on: June 01,2024

Research: Subset of breast cancers have two PIK3CA mutations on the same allele

by Bob Yirka , Medical XpressCredit: CC0 Public DomainA team of researchers affiliated with a large number of institutions in the U.S. has found that a subgroup of breast cancers have two PIK3CA mutat

Updated on:June 01,2024

Discovery adds to evidence that some children are predisposed to develop leukemia

by St. Jude Children's Research HospitalCharles Mullighan, MBBS, M.D., Michelle Churchman Ph.D., Max Qian PhD, Jun Yang Ph.D. Credit: St. Jude Children's Research Hospital / Seth DixonSt.

Updated on: April 14,2024

Discovery adds to evidence that some children are predisposed to develop leukemia

by St. Jude Children's Research HospitalCharles Mullighan, MBBS, M.D., Michelle Churchman Ph.D., Max Qian PhD, Jun Yang Ph.D. Credit: St. Jude Children's Research Hospital / Seth DixonSt.

Updated on:April 14,2024

Attacking metastatic prostate cancer early with combination treatment approach improves outcomes in preliminary study

by Denise Heady,University of California, Los AngelesProstate cancer cells. Credit: NIH Image GalleryA team of UCLA Health Jonsson Comprehensive Cancer Center investigators has shown the combina

Updated on: March 30,2024

Attacking metastatic prostate cancer early with combination treatment approach improves outcomes in preliminary study

by Denise Heady,University of California, Los AngelesProstate cancer cells. Credit: NIH Image GalleryA team of UCLA Health Jonsson Comprehensive Cancer Center investigators has shown the combina

Updated on:March 30,2024

Study increases understanding of what makes multiple recurrent meningiomas the most aggressive form of brain tumor

by Graciela Gutierrez,Baylor College of MedicineWES reveals a greater burden of chromosomal losses in MRMs. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adn4419Researchers at B

Updated on: November 09,2024

Study increases understanding of what makes multiple recurrent meningiomas the most aggressive form of brain tumor

by Graciela Gutierrez,Baylor College of MedicineWES reveals a greater burden of chromosomal losses in MRMs. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adn4419Researchers at B

Updated on:November 09,2024

Number of cancer treatments provided decreased in first year of COVID-19

by Elana GotkineIn the first year of the pandemic, there was a significant decrease in the number of cancer treatments provided, resulting from a decrease in the number of cancer diagnoses, according

Updated on: May 05,2024

Number of cancer treatments provided decreased in first year of COVID-19

by Elana GotkineIn the first year of the pandemic, there was a significant decrease in the number of cancer treatments provided, resulting from a decrease in the number of cancer diagnoses, according

Updated on:May 05,2024

ASCO: low-dose chemo benefits advanced gastroesophageal cancer

(HealthDay)—For frail and elderly patients with advanced gastroesophageal cancer (aGOAC), low-dose chemotherapy is noninferior to high-dose chemotherapy for progression-free survival, according to a s

Updated on: March 30,2024

ASCO: low-dose chemo benefits advanced gastroesophageal cancer

(HealthDay)—For frail and elderly patients with advanced gastroesophageal cancer (aGOAC), low-dose chemotherapy is noninferior to high-dose chemotherapy for progression-free survival, according to a s

Updated on:March 30,2024

New insight into aggressive breast cancers

by Cardiff UniversityCredit: CC0 Public DomainScientists from Cardiff University have uncovered a protein which drives aggressive breast cancer and could be targeted for developing new and improv

Updated on: March 06,2024

New insight into aggressive breast cancers

by Cardiff UniversityCredit: CC0 Public DomainScientists from Cardiff University have uncovered a protein which drives aggressive breast cancer and could be targeted for developing new and improv

Updated on:March 06,2024